Activity for Remnant Ablation in Patients with Differentiated Thyroid Cancer: A Systematic Review
نویسندگان
چکیده
Cancer Research UK & UCL Cancer Trials Centre (A.H.), University College London, London NW1 2ND, United Kingdom; Formerly Thyroid Cancer Unit (C.H.), Royal Marsden Hospital, London SW3 6JJ, United Kingdom; Newcastle General Hospital (U.M.), Newcastle NE4 6BE, United Kingdom; Chelsea and Westminster Hospital (M.H.), London SW10 9NH, United Kingdom; and Division of Medical Sciences (J.A.F.), University of Birmingham, Queen Elizabeth Hospital, Birmingham B15 2TH, United Kingdom
منابع مشابه
Thyroid hormone replacement one day before 131I therapy in patients with well-differentiated thyroid cancer
Objective: The current study aimed to determine the efficacy of radioiodine-131 (131I) ablation therapy with thyroid hormone replacement one day before 131I administration in patients with well-differentiated thyroid cancer (DTC). Methods: This retrospective study included 29 patients who underwent 131I therapies twice for DTC during 6-12 months. Since all the patients obviously had residual l...
متن کاملFactors affecting discharge time of well differentiated thyroid cancer patients receiving 131I therapy: Five years’ experience
Introduction:The post-surgical management of patients with differentiated thyroid cancer include ablation of remnant local and distant metastatic tissues with 131I therapy, which accentuates isolation of the patient in order to avoid unnecessary radiation exposure to the care givers, general public and the environment. The duration of isolation is subject to the redu...
متن کامل131I activity for remnant ablation in patients with differentiated thyroid cancer: A systematic review.
CONTEXT Radioiodine ablation of the thyroid remnant after thyroidectomy is commonly performed in the management of patients with differentiated thyroid cancer. Although many centers administer an activity of 100 mCi, there is uncertainty over using a lower activity. OBJECTIVE A systematic review of the published literature was used to compare the success rates of remnant ablation using approx...
متن کاملThe Use of Low Dose in Radioiodine Ablation of Well-Differentiated Thyroid Cancer
Remnant thyroid ablation after thyroidectomy with radioiodine (RAI, I-131) is considered the standard of care for low risk patients with well-differentiated thyroid cancer (WDTC). The choice of activity for therapy is usually empirically determined according to the tumor characteristics and the patient’s age. Many guidelines recommend a range of 1.1 to 3.7 GBq (30 to 100 mCi), although the choi...
متن کاملHow to manage patients with undetectable thyroglobulin but thyroid residue after radioiodine ablative therapy in differentiated thyroid carcinoma, retreatment or observation?
Introduction:Differentiated thyroid carcinoma (DTC) follow-up after thyroidectomy and radioiodine-ablation is performed mainly by thyroglobulin (Tg), diagnostic iodine-131 whole body scan (DxWBS) and sonography. Some patients with undetectable Tg have thyroid-bed uptake after ablation in whom decision making regarding the need for retreatment is still controversial. Me...
متن کامل